You are here

Michel Revel

Prof. Michel Revel

 A drug developed  by InterPharm Laboratories Ltd. was first isolated and cloned by Prof. Michel Revel.

Prof. Michel Revel

Prof. Michel Revel spent more than 30 years studying interferons, which play a key role in the immune system. In the late 1970s, he isolated the...

Prof. Michel Revel
Prof. Michel Revel was elected a member of the Israel Academy of Sciences and Humanities.
Four graduates of the Weizmann Institute's feinberg graduate School, who today form the senior staff of Pharmos. Left to rigth: Dr. Michael Schickler, Prof. Haim Aviv, Dr. Cynthia Webb, and Dr. Vered Lavie

Prof. Haim Aviv is starting his sixth bio-tech company

The Benefits of Immaturity
A method developed in Institute labs could keep stem cells "fresh" for longer
New Molecule Boosts Stem Cell Survival
Weizmann Institute researchers have developed a molecule that allows blood stem cells - the body's most primitive, immature...
Rebif Spells Relief

Clinical trials of the multiple sclerosis drug, Rebif, are proving its effectiveness